| Association Between Natural Hypoglycemic Foods and Blood Sugar Level: A Pilot Study (NCT05272839) | Antenna Foundation | 2022-04-01 |
| A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Individual Components in Healthy Chinese Subjects (NCT05108350) | Shandong Suncadia Medicine Co., Ltd. | 2021-11-09 |
| A Study to Assess the Effect of Food on HR20033 and Pharmacokinetic After Multiple Dose in Healthy Volunteers (NCT05120219) | Shandong Suncadia Medicine Co., Ltd. | 2021-10-13 |
| Impact of the Rapid Normalization of Chronic Hyperglycemia and the Practice of Moderate Physical Activity on the "Receptor Activator of Nuclear Factor-kappa B Ligand / Osteoprotégérine (RANKL / OPG) System in Patients Living With Type II Diabetes (NCT04893135) | Centre Hospitalier Sud Francilien | 2021-10-11 |
| Dietary Approaches to Stop Hypertension for Diabetes (NCT04286555) | Johns Hopkins University | 2021-06-02 |
| A Study to Investigate the PK and Safety of CKD-393 (NCT04768673) | Chong Kun Dang Pharmaceutical | 2021-03-26 |
| Mass Balance and Biotransformation of [14C]HSK7653 in Human (NCT04540016) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2020-11-15 |
| Postbiotic MBS and Metformin Combination in Patients With T2DM (NCT04639492) | Microbio Co Ltd | 2020-11-02 |
| Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes (NCT06224803) | Global Preventive Medicine Biotech Co., Ltd. | 2020-08-26 |
| Educational Intervention Targeting Statin Therapy and Compliance in Diabetic Patients (NCT04499846) | Lille Catholic University | 2020-06-11 |
| INTEGRATE-D: A Pilot Test to Support Integration of Medical and Psychosocial Care for People With Type II Diabetes (NCT04461405) | Oregon Health and Science University | 2020-03-01 |
| Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study. (NCT05074732) | Health Service Executive, Ireland | 2019-12-01 |
| SOKARY Mobile Application With Type II Diabetes (NCT04843592) | Magda Bayoumi | 2019-08-30 |
| Peer Support Dyads in Churches (NCT03463941) | Duke University | 2019-01-05 |
| Supplementation of Brown Seaweed on Insulin Resistance of NAFLD Patients With Pre- or Type 2-Diabetes (NCT04715776) | Taipei Medical University WanFang Hospital | 2018-12-10 |
| Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults (NCT03646799) | Chong Kun Dang Pharmaceutical | 2018-08-30 |
| Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging (NCT03498001) | Centre Hospitalier Universitaire Dijon | 2018-04-16 |
| Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin (NCT02984644) | The University of Texas Health Science Center at San Antonio | 2017-09-06 |
| Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects (NCT03027960) | Yale University | 2017-06-27 |
| Social Incentives to Improve Diabetes (NCT02961192) | University of Pennsylvania | 2017-02-13 |
| Role of Gastrointestinal Microbes on Digestion of Resistant Starch and Tryptophan Availability to Humans (NCT02974699) | Wayne State University | 2017-01-01 |
| Determination of the Optimum Cut-off Value of Type 2 Diabetes Diagnosis Among Chinese Population(SENSIBLE STUDY II) (NCT03024788) | Zhongda Hospital | 2017-01-01 |
| Providing Preventive Periodontal Treatment to Hospitalized Patients With Diabetes (NCT02914743) | Massachusetts General Hospital | 2016-11-01 |
| Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics (NCT01001962) | Aristotle University Of Thessaloniki | 2016-01-01 |
| Salivary Transcriptome Biomarkers for Early Diabetes Detection (NCT02673762) | PeriRx | 2016-01-01 |
| Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study (NCT02471794) | Duke University | 2015-12-01 |
| Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes (NCT02586129) | Yuhan Corporation | 2015-11-04 |
| Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3) (NCT02947620) | Daewoong Pharmaceutical Co. LTD. | 2015-08-01 |
| Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin (NCT02429258) | AstraZeneca | 2015-05-01 |
| Mobile Unit Screening of Pathologies Associated With Chronic Diseases - Feasibility (NCT02214056) | Centre Hospitalier Universitaire de Nīmes | 2015-02-01 |
| Clinical Trial for PB-119 in Healthy Subjects (Phase I) (NCT02084251) | PegBio Co., Ltd. | 2014-02-01 |
| Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers (NCT02015910) | Georgetown University | 2014-01-01 |
| Initial Clinical Evaluation of an Endoscopic Therapy for Type 2 Diabetes (NCT01927562) | Fractyl Health Inc. | 2013-07-13 |
| Measuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst Scaling (NCT02637609) | Johns Hopkins Bloomberg School of Public Health | 2013-07-01 |
| Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice Experiment (NCT02637622) | Johns Hopkins Bloomberg School of Public Health | 2013-07-01 |
| Fatty Liver Study in Patients With Type II Diabetes (NCT02365233) | The University of Texas Medical Branch, Galveston | 2013-05-01 |
| Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes (NCT01804777) | University of New Mexico | 2013-03-01 |
| Using EEG Operant Conditioning to Improve Trait Self-Control and Promote Healthy Behavior (NCT01801254) | University of Rochester | 2013-02-01 |
| Type II Diabetes Influence on Left Ventricular Remodeling and Outcomes in Patients Undergoing Aortic Valve Replacement Surgery. (NCT01862237) | Hospices Civils de Lyon | 2012-12-01 |
| Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration (NCT01698528) | Joslin Diabetes Center | 2012-10-01 |
| The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy (NCT02127762) | Ottawa Hospital Research Institute | 2012-09-01 |
| The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients (NCT04569214) | Boston Therapeutics | 2012-09-01 |
| Activator and Type II Diabetics (NCT01782092) | Life University | 2012-08-01 |
| Diabetes Mellitus Community Based Screening in Minority Populations (NCT01591525) | Ethnicity and Disease Community Empowerment Center | 2012-06-01 |
| Periodontal Treatment Response in Type II Diabetic Patients (NCT01881074) | University of Florida | 2012-06-01 |
| Effects of Purple Vegetables on Cardiovascular Disease (CVD) Risk Factors (NCT01564498) | University of Guelph | 2012-04-01 |
| Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 (NCT01619332) | Novartis Pharmaceuticals | 2012-03-01 |
| Intensive Discharge Intervention in Diabetes (NCT02122926) | Brigham and Women's Hospital | 2011-12-01 |
| Biospecimens for Identification of Diseases of the Pancreas. (NCT01392027) | University of Michigan | 2011-04-01 |
| The Effect of Gastric Bypass Surgery on Diabetes (NCT01330251) | University of Oulu | 2011-01-01 |
| Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and Obesity (NCT00985114) | Morphic Medical Inc. | 2009-10-01 |
| Fracture Risk With Thiazolidinediones (NCT01055223) | GlaxoSmithKline | 2009-05-01 |
| Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes (NCT00856908) | AstraZeneca | 2009-02-01 |
| Outreach for Diabetes Cure (NCT01384045) | University of Colorado, Denver | 2009-02-01 |
| To Evaluate 24-hr Glucose After OD vs BD AZD1656 (NCT00819884) | AstraZeneca | 2009-01-01 |
| Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 Diabetes (NCT00694278) | Ferzli, George S., M.D. F.A.C.S. | 2008-06-01 |
| To Demonstrate the Relative Bioavailability of Metformin HCL 500 mg Extended Release (XR) Tablets Under Fasting Conditions (NCT00882882) | Sandoz | 2001-06-01 |